HCPLive Network

Smoke-Free Legislation Has Significant Health Benefits

TUESDAY, April 1, 2014 (HealthDay News) -- Introduction of smoke-free legislation is associated with reductions in preterm birth and hospital attendance for asthma, according to a review published online March 28 in The Lancet.

Jasper V. Been, PhD, from Maastricht University in the Netherlands, and colleagues conducted a systematic literature review to examine the impact of smoke-free legislation on perinatal and child health. Data were included from 11 studies involving more than 25 million births and 247,168 asthma exacerbations.

The researchers found that all studies used interrupted time-series designs, and they described local bans (five North American studies) and national bans (six European studies). One study had a high risk of bias, while six and four had moderate and low risk, respectively. There were correlations between smoke-free legislation and reductions in preterm birth (four studies, −10.4 percent; P = 0.016) and hospital attendances for asthma (three studies, −10.1 percent; P = 0.0001). There was no significant effect on low birth weight identified (six studies, −1.7 percent; P = 0.31).

"Smoke-free legislation is associated with substantial reductions in preterm births and hospital attendance for asthma," the authors write. "Together with the health benefits in adults, this study provides strong support for World Health Organization recommendations to create smoke-free environments."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.

Further Reading
If the results of a recent study are proven to last, then the previously held belief concerning the relationship between tuberculosis and the use of corticosteroids could be considered incomplete.
Cost-related barriers to care for children with asthma are concentrated in low-income families with higher cost-sharing levels, according to a study published online May 19 in JAMA Pediatrics.
For children aged 2 to 15 years, asthma exacerbations and asthma medication prescriptions peak in September, correlating with the start of the school year, according to a study published online March 10 in Pediatrics.
Twelve weeks of the novel AMG 157 antibody treatment may benefit patients with poorly controlled asthma, according to a study published online May 20 in the New England Journal of Medicine. This research was published to coincide with the annual meeting of the American Thoracic Society, held from May 16 to 21 in San Diego.
Researchers reported no treatment effects after 12 weeks in a population of patients with persistent moderate to severe allergic asthma.
Asthma prolongs time to pregnancy, according to a study published online Nov. 14 in the European Respiratory Journal
Although the mechanisms of disease severity for this form of asthma are not fully understood, progress has been made in identifying promising targets for new treatments.
More Reading